Poor data quality, inadequate risk controls, escalating costs or unclear business value are reasons that at least 30% of generative AI (GenAI) projects will be abandoned after proof of concept by the end of 2025, according to Gartner, Inc.
“After last year's hype, executives are impatient to see returns on GenAI Investments, yet organizations are struggling to prove and realize value," said Rita Sallam, VP Analyst at Gartner, in a statement. "As the scope of initiatives widen, the financial burden of developing and deploying GenAI models is increasingly felt.”
One the issues is the ability to justify the substantial investment in GenAI for productivity enhancement, which can be difficult to directly translate into financial benefit, according to Gartner. The research show that many organizations are leveraging GENAI to transform their business models and create new business opportunities. However the costs of this is high, , ranging from $5 million to $20 million.
“Unfortunately, there is no one size fits all with GenAI, and costs aren’t as predictable as other technologies,” said Sallam. “What you spend, the use cases you invest in and the deployment approaches you take, all determine the costs. Whether you’re a market disruptor and want to infuse AI everywhere, or you have a more conservative focus on productivity gains or extending existing processes, each has different levels of cost, risk, variability and strategic impact.”
Gartner research indicates GenAI requires a higher tolerance for indirect, future financial investment criteria versus immediate return on investment (ROI). Historically, many CFOs have not been comfortable with investing today for indirect value in the future. This reluctance can skew investment allocation to tactical versus strategic outcomes.
Realizing Business Value
Earlier adopters across industries and business processes are reporting a range of business improvements that vary by use case, job type and skill level of the worker. According to a recent Gartner survey, respondents reported 15.8% revenue increase, 15.2% cost savings and 22.6% productivity improvement on average. The survey of 822 business leaders was conducted between September and November 2023.
“This data serves as a valuable reference point for assessing the business value derived from GenAI business model innovation,” said Sallam. “But it’s important to acknowledge the challenges in estimating that value, as benefits are very company, use case, role and workforce specific. Often, the impact may not be immediately evident and may materialize over time. However, this delay doesn’t diminish the potential benefits.”
